Evidence map›Paper›PMID 32755168›Full record

ArticleAJR. American journal of roentgenology2020

Prospective Evaluation of

Sonia Gaur, Esther Mena, Stephanie A Harmon, Maria L Lindenberg, Stephen Adler, Anita T Ton, Joanna H Shih, Sherif Mehralivand, Maria J Merino, Bradford J Wood and 5 more

Open access · greenAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in AJR. American journal of roentgenology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Radiology. Imaging cancer · 2022
    Pooled it
  3. Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2026
    Article
  4. Article
  5. Preclinical Imaging of Prostate Cancer.Seminars in nuclear medicine · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. A Pilot Study of DynamicMolecular imaging and biology · 2022
    Article
  10. Article
  11. Translating a radiolabeled imaging agent to the clinic.Advanced drug delivery reviews · 2022
    Review
  12. Article
  13. Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Sonia GaurMolecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, Rm B3B85, Bethesda, MD 20814.
Esther MenaMolecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, Rm B3B85, Bethesda, MD 20814.
Stephanie A HarmonClinical Research Directorate, Leidos Biomedical Research, Inc., National Cancer Institute Campus at Frederick, Frederick, MD.
Maria L LindenbergMolecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, Rm B3B85, Bethesda, MD 20814.
Stephen AdlerClinical Research Directorate, Leidos Biomedical Research, Inc., National Cancer Institute Campus at Frederick, Frederick, MD.
Anita T TonMolecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, Rm B3B85, Bethesda, MD 20814.
Joanna H ShihBiometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, MD.
Sherif MehralivandUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Maria J MerinoLaboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Bradford J WoodCenter for Interventional Oncology, Clinical Center, National Institutes of Health, Bethesda, MD.
Peter A PintoUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Ronnie C MeaseRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD.
Martin G PomperRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD.
Peter L ChoykeMolecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, Rm B3B85, Bethesda, MD 20814.
Baris TurkbeyMolecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, Rm B3B85, Bethesda, MD 20814.
Johns Hopkins University · USMichigan Medicine · USNational Institutes of Health · USNational Institutes of Health Clinical Center · US

Funding

Center for Interventional OncologyZIDBC011242 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WOOD, BRADFORD J · 2009 to 2025
$18.7M
Prostate Cancer ImagingZ01BC010655 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2005 to 2008
$2.1M
SURGICAL PATHOLOGYZ01SC000853 · SC · DIVISION OF CLINICAL SCIENCES - NCI · PI MERINO NEUMANN, MARIA · 1996 to 2008
$823k
Prostate SectionZ01BC011081 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PINTO, PETER · 2008 to 2008
$99k
Interventional OncologyZIACL040015 · CLC · CLINICAL CENTER · PI WOOD, BRADFORD · 2009 to 2025
$0k
Intramural NIH HHS Z01 BC010655Intramural NIH HHS Z01 BC011081Intramural NIH HHS Z01 SC000853Intramural NIH HHS ZID BC011242NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAged, 80 and overHumansLysineMaleMiddle AgedMultiparametric Magnetic Resonance ImagingNeoplasm GradingPositron Emission Tomography Computed TomographyProspective StudiesProstatic NeoplasmsRadiopharmaceuticalsSensitivity and SpecificityTumor BurdenUrea2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acidLysineRadiopharmaceuticalsUreaMRImultiparametric MRIPETprostateprostate cancerprostate-specific membrane antigen (PSMA)

Identifiers

PMID32755168
PMCPMC8974973
OpenAlexW3040853700

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.